Trials / Completed
CompletedNCT05850637
Evaluate the Effectiveness and Toxicity of Adjuvant Ultra-hypofractionated Radiotherapy for Breast Cancer
Phase II Study to Evaluate the Effectiveness and Toxicity of Adjuvant Ultra-hypofractionated Radiotherapy for the Treatment of Early and Locally Advanced Breast Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Prevent Senior Institute · Academic / Other
- Sex
- Female
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
Prospective phase 2 study to evaluate the safety and efficacy of ultra-hypofractionated adjuvant radiotherapy in 5 fractions of 5.7 Gy in patients aged over 65 years.
Detailed description
Prospective phase 2 non-randomized single-arm study to evaluate the safety and efficacy of ultra-hypofractionated adjuvant radiotherapy in 5 fractions of 5.7 Gy in patients aged over 65 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | adjuvant ultra-hypofractionated radiotherapy | adjuvant ultra-hypofractionated radiotherapy for the treatment of early and locally advanced breast cancer |
Timeline
- Start date
- 2019-01-30
- Primary completion
- 2021-02-11
- Completion
- 2023-04-01
- First posted
- 2023-05-09
- Last updated
- 2024-04-04
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05850637. Inclusion in this directory is not an endorsement.